Register entry
Hubei Haosun Pharmaceutical Co., Ltd.
- Registered sites
- 1
- Drug products
- 11
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Hubei Haosun Pharmaceutical Co., Ltd. | EzhouChina | Active ingredient (API) manufacture | 3005178749 |
Catalogue
Marketed products
11Showing 11 of 11.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | DASATINIB ANHYDROUS | POWDER | BULK INGREDIENT |
| - | DESVENLAFAXINE SUCCINATE | POWDER | BULK INGREDIENT |
| - | Dasatinib | POWDER | BULK INGREDIENT |
| - | Docetaxel Anhydrous | POWDER | BULK INGREDIENT |
| - | FLUMAZENIL | POWDER | BULK INGREDIENT |
| - | Granisetron | POWDER | BULK INGREDIENT |
| - | Granisetron Hydrochloride | POWDER | BULK INGREDIENT |
| - | Irinotecan Hydrochloride | POWDER | BULK INGREDIENT |
| - | NEOSTIGMINE METHYLSULFATE | POWDER | BULK INGREDIENT |
| - | NILOTINIB HYDROCHLORIDE MONOHYDRATE | POWDER | BULK INGREDIENT |
| - | Temozolomide | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.